Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,017 | 797 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,268 | 12 | $0 (2024) |
| Novo Nordisk Inc | $1,231 | 93 | $0 (2024) |
| Lilly USA, LLC | $1,123 | 80 | $0 (2024) |
| PFIZER INC. | $1,036 | 150 | $0 (2024) |
| ABBVIE INC. | $711.05 | 42 | $0 (2024) |
| Amgen Inc. | $670.63 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $622.42 | 55 | $0 (2023) |
| GlaxoSmithKline, LLC. | $576.81 | 65 | $0 (2023) |
| Allergan, Inc. | $548.46 | 50 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $400.46 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,821 | 91 | AIMMUNE THERAPEUTICS, INC. ($353.47) |
| 2023 | $1,596 | 103 | Lilly USA, LLC ($262.71) |
| 2022 | $1,603 | 105 | Lilly USA, LLC ($292.70) |
| 2021 | $1,674 | 116 | AbbVie Inc. ($305.82) |
| 2020 | $809.73 | 45 | AstraZeneca Pharmaceuticals LP ($180.56) |
| 2019 | $1,224 | 110 | AstraZeneca Pharmaceuticals LP ($198.55) |
| 2018 | $1,168 | 111 | Allergan Inc. ($214.51) |
| 2017 | $1,122 | 116 | PFIZER INC. ($194.09) |
All Payment Transactions
797 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Oncology | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Biological | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 08/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $45.90 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 59 | 11,584 | 24,402 | $715,582 | $565,937 |
| 2022 | 59 | 15,144 | 36,090 | $1.1M | $792,469 |
| 2021 | 60 | 15,760 | 45,201 | $1.2M | $909,627 |
| 2020 | 64 | 15,282 | 43,645 | $1.1M | $791,572 |
All Medicare Procedures & Services
242 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 670 | 2,248 | $263,396 | $177,566 | 67.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 408 | 408 | $48,503 | $47,565 | 98.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 256 | 394 | $64,644 | $43,677 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 307 | 680 | $56,850 | $41,029 | 72.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 412 | 412 | $31,370 | $30,480 | 97.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 633 | 2,055 | $21,798 | $21,229 | 97.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 645 | 2,622 | $16,605 | $16,244 | 97.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 548 | 1,228 | $16,524 | $16,093 | 97.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 638 | 2,242 | $14,574 | $14,198 | 97.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 183 | 184 | $12,869 | $12,611 | 98.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 481 | 767 | $12,915 | $12,597 | 97.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $10,650 | $8,361 | 78.5% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 71 | 79 | $7,613 | $7,323 | 96.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 200 | 352 | $18,047 | $7,322 | 40.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 254 | 405 | $7,471 | $7,280 | 97.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 36 | $9,147 | $6,833 | 74.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 411 | 411 | $6,950 | $6,814 | 98.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 480 | 765 | $6,919 | $6,748 | 97.5% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 507 | 1,131 | $5,889 | $5,736 | 97.4% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 71 | 79 | $5,556 | $5,366 | 96.6% |
| 83735 | Magnesium level | Office | 2023 | 395 | 716 | $4,811 | $4,694 | 97.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 140 | 161 | $4,766 | $4,671 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 198 | 488 | $4,762 | $4,620 | 97.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 79 | 89 | $4,591 | $4,425 | 96.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 175 | 297 | $4,487 | $4,377 | 97.6% |
About Dr. Paul Wibbels, MD
Dr. Paul Wibbels, MD is a Internal Medicine healthcare provider based in Hastings, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336142900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Wibbels, MD has received a total of $11,017 in payments from pharmaceutical and medical device companies, with $1,821 received in 2024. These payments were reported across 797 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($11,017).
As a Medicare-enrolled provider, Wibbels has provided services to 57,770 Medicare beneficiaries, totaling 149,338 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 242 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hastings, NE
- Active Since 05/27/2005
- Last Updated 01/21/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1336142900
Products in Payments
- Ozempic (Drug) $676.29
- BREZTRI (Drug) $658.03
- FARXIGA (Drug) $596.46
- MOUNJARO (Drug) $398.78
- ZENPEP (Drug) $380.99
- XARELTO (Drug) $370.04
- TRULICITY (Drug) $364.71
- TRADJENTA (Drug) $343.06
- CHANTIX (Drug) $333.65
- TRELEGY ELLIPTA (Drug) $308.11
- UBRELVY (Drug) $291.80
- Cologuard Collection Kit (Device) $263.11
- EVENITY (Biological) $228.90
- Otezla (Drug) $228.82
- ELIQUIS (Drug) $221.56
- QULIPTA (Drug) $216.02
- BYSTOLIC (Drug) $214.70
- ENTRESTO (Drug) $205.40
- Kerendia (Drug) $186.84
- VIBERZI (Drug) $186.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hastings
Justin Wenburg, Md, MD
Internal Medicine — Payments: $13,260
Dr. Douglas Hentzen, M.d, M.D
Internal Medicine — Payments: $12,047
Richard French, Md, MD
Internal Medicine — Payments: $7,624
Matthew Stritt, Md, MD
Internal Medicine — Payments: $5,750
Michelle Seizys, Md, MD
Internal Medicine — Payments: $5,136
David Little, Md, MD
Internal Medicine — Payments: $3,987